Share on LinkedInShare on LinkedIn

ARTICLE · 01 DECEMBER 2020

COVID-19: Update On Clinical Research Precautions

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

An accelerated assessment procedure will be applied to applications regarding COVID-19-related clinical trials.

TurkeyCoronavirus (COVID-19)

 

Dicle Dogan and Fatma Sevde Tan, Gun + Partners

On 25 July 2020, the Turkish Medicines and Medical Devices Agency published an update to its announcement titled Precautions to be taken in Clinical Research due to the COVID-19 pandemic (Turkish language) that was originally published on 20 March 2020. The update reflects feedback collected from the industry.

The updated announcement states the following:

  • Applications to conduct online meetings between research personnel during the pandemic can now be made to the Agency five working days before the meeting, instead of 30 days.
  • Within the scope of clinical trials, face-to-face trainings may now be held online.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from